Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis

Completed

• Conditions: Osteoarthritis
• Interventions: Drug: Synvisc®

• Registration Number: NCT02195492
• Lead Sponsor: Boehringer Ingelheim

Brief Summary

Retrospective collection of data, aimed at a better knowledge of the context of use of Synvisc® among the patients practising a regular activity (professional/leisure), and at evaluating the different practices and their results.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-04
• Primary Completion: 2003-03
• Status Verified: 2014-07
• Study First Submitted: 2014-07-18
• Study First Submitted QC: 2014-07-18
• Last Update Submitted: 2014-07-18
• Study First Posted: 2014-07-21
• Last Update Posted: 2014-07-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

• use of Synvisc®
• patients practising a regular activity (professional/leisure)

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Synvisc®	Synvisc®	-

Primary Outcome Measures

Name	Time	Method
Amount of medication consumed	up to 1 year	antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs)

Secondary Outcome Measures

Name	Time	Method
Patient-assessed benefit on a 2-point verbal rating scale	up to 1 year